- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT06001918
Estudo Clínico do Sistema Nectero EAST (stAAAble)
Ensaio Clínico Controlado Randomizado (ECR) do Sistema Nectero EAST para Estabilização de Aneurismas da Aorta Abdominal (AAA) de Pequeno a Médio Porte: Avaliação da Eficácia.
The purpose of this randomized clinical trial is to treat patients with small to mid-sized abdominal aortic aneurysms (AAA), maximum diameter of 3.5 cm to 5.0 cm, using a locally delivered, single-dose endovascular treatment. The main question the study aims to answer is to demonstrate efficacy of the product for stabilization of these small to mid-sized AAA.The study will compare the treatment group to the typical standard of care for these patients, surveillance. All subjects will be followed at designated intervals at 30/60 days, 6, 12, 18 and 24 months with continued follow-up annually for up to 5 years.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Fase 2
- Fase 3
Contactos e Locais
Contato de estudo
- Nome: Charlene Knape
- Número de telefone: 866-755-4744
- E-mail: cknape@necteromedical.com
Estude backup de contato
- Nome: Tracy Roberts
- Número de telefone: (303)3964603
- E-mail: troberts@necteromedical.com
Locais de estudo
-
-
New South Wales
-
Randwick, New South Wales, Austrália, 2031
- Recrutamento
- Prince of Wales Private Hospital- POW Vascular Institute
-
Investigador principal:
- Ramon Varcoe
-
Contato:
- Jade Goh
- Número de telefone: 04 87 369 396
- E-mail: pow.vascular.institute@gmail.com
-
-
-
-
Arizona
-
Scottsdale, Arizona, Estados Unidos, 85258
- Recrutamento
- Honor Health Scottsdale Shea Medical Center
-
Investigador principal:
- Hasan Aldailami, MD
-
Contato:
- HonorHealth Cardiovascular Research
- Número de telefone: 480-323-1046
-
-
Colorado
-
Aurora, Colorado, Estados Unidos, 80045
- Ativo, não recrutando
- University of Colorado
-
-
District of Columbia
-
Washington D.C., District of Columbia, Estados Unidos, 20010
- Recrutamento
- Medstar Washington Hospital Center
-
Investigador principal:
- Steven Abramowitz, MD
-
Contato:
- Kassaye Sesaba, MD
- Número de telefone: 202-877-7452
- E-mail: Kassaye.T.Sesaba@medstar.net
-
Contato:
- Suman Singh, MD
- Número de telefone: (202) 877-8475
- E-mail: Suman.Singh@Medstar.net
-
-
Florida
-
Delray Beach, Florida, Estados Unidos, 33446
- Recrutamento
- Prime Vascular Institute
-
Investigador principal:
- Joseph Ricotta, MD
-
Contato:
- Jordan Sprechman
- Número de telefone: 561-495-3145
- E-mail: Jordan.Sprechman@tenethealth.com
-
Contato:
- Alexia Medick
- E-mail: Alexia.Medick@tenethealth.com
-
-
Georgia
-
Augusta, Georgia, Estados Unidos, 30912
- Recrutamento
- Medical College of Georgia
-
Investigador principal:
- William Jordan, MD
-
Contato:
- Natasha Flores
- E-mail: nflores@augusta.edu
-
Contato:
- Candelario Laserna
- Número de telefone: 706-721-2199
- E-mail: calaserna@augusta.edu
-
-
Illinois
-
Chicago, Illinois, Estados Unidos, 60637
- Recrutamento
- University of Chicago
-
Contato:
- MacKenton Johnson
- Número de telefone: 773-795-3639
- E-mail: mackenton@bsd.uchicago.edu
-
Investigador principal:
- Ross Milner, MD
-
Elk Grove, Illinois, Estados Unidos, 60007
- Ainda não está recrutando
- Ascension Alexian Brothers
-
Investigador principal:
- Jack Chamberlin, MD
-
-
Maine
-
Scarborough, Maine, Estados Unidos, 04074
- Recrutamento
- MaineMed Vascular Surgery
-
Investigador principal:
- Kristina Giles, MD
-
Contato:
- Kathryn Ackermann
- E-mail: kathryn.ackermann@mainehealth.org
-
-
Massachusetts
-
Boston, Massachusetts, Estados Unidos, 02114
- Recrutamento
- Massachusetts General Hospital
-
Investigador principal:
- Nikolaos Zacharias, MD
-
Contato:
- Bonnie Chen
- E-mail: BCHEN13@mgh.harvard.edu
-
Boston, Massachusetts, Estados Unidos, 02215
- Recrutamento
- Beth Israel Deaconess Medical Center
-
Investigador principal:
- Marc Schermerhorn, MD
-
Contato:
- Monica Goyal
- Número de telefone: 617-632-7534
- E-mail: mgoyal@bidmc.harvard.edu
-
Contato:
- Fernando Moreno
- E-mail: fmoreno@bidmc.harvard.edu
-
Worcester, Massachusetts, Estados Unidos, 01655
- Recrutamento
- University of Massachusetts
-
Contato:
- Shauneen Valliere
- E-mail: shauneen.valliere@umassmed.edu
-
Investigador principal:
- Andres Schanzer, MD
-
-
Michigan
-
Royal Oak, Michigan, Estados Unidos, 48073
- Recrutamento
- Beaumont Health
-
Investigador principal:
- Graham Long, MD
-
Contato:
- Lisa Bliss
- E-mail: lisa.bliss@corewellhealth.org
-
-
Missouri
-
St Louis, Missouri, Estados Unidos, 63110
- Recrutamento
- Washington University School of Medicine
-
Investigador principal:
- Luis Sanchez, MD
-
Contato:
- Briana K Langrehr, BSN
- E-mail: briana.l@wustl.edu
-
-
Nebraska
-
Omaha, Nebraska, Estados Unidos, 68198
- Recrutamento
- University of Nebraska Medical Center
-
Investigador principal:
- Jonathan Thompson, MD
-
Contato:
- Jarod Phillips
- E-mail: jarphillips@unmc.edu
-
-
New Hampshire
-
Lebanon, New Hampshire, Estados Unidos, 03766
- Recrutamento
- Dartmouth Hitchcock Medical Center
-
Investigador principal:
- Rebecca Scully, MD
-
Contato:
- Pauline Sirrell
- E-mail: pauline.sirrell@hitchcock.org
-
-
New York
-
Rochester, New York, Estados Unidos, 14642
- Recrutamento
- University of Rochester
-
Contato:
- Mary Bourret
- E-mail: Mary_Bourret@URMC.Rochester.edu
-
Investigador principal:
- Doran Mix, MD
-
Stony Brook, New York, Estados Unidos, 11794
- Ainda não está recrutando
- Stony Brook Medicine
-
Investigador principal:
- Rabih Chaer, MD
-
Contato:
- Daria Shavarina
- E-mail: Daria.Shavarina@stonybrookmedicine.edu
-
-
North Carolina
-
Durham, North Carolina, Estados Unidos, 27710
- Recrutamento
- Duke University Medical Center
-
Investigador principal:
- Chandler Long, MD
-
Contato:
- Ellen Burkett
- Número de telefone: (919)681-1878
- E-mail: ellen.jones@duke.edu
-
-
Ohio
-
Cincinnati, Ohio, Estados Unidos, 45219
- Recrutamento
- The Christ Hospital
-
Contato:
- Jamie Elkins
- E-mail: Jamie.Elkins@thechristhospital.com
-
Investigador principal:
- Geoff Answini, MD
-
Cleveland, Ohio, Estados Unidos, 44106
- Recrutamento
- University Hospitals Cleveland
-
Investigador principal:
- Jae Cho, MD
-
Contato:
- Amy Kluge
- E-mail: Amy.Kluge@UHhospitals.org
-
Cleveland, Ohio, Estados Unidos, 44195
- Recrutamento
- Cleveland Clinic
-
Investigador principal:
- Francis Caputo, MD
-
Contato:
- Laurie Ann Moennich
- E-mail: MOENNIL@ccf.org
-
Columbus, Ohio, Estados Unidos, 43210
- Recrutamento
- The Ohio State University Wexner Medical Center
-
Contato:
- Subh Das
- Número de telefone: 614-366-6596
- E-mail: subhashish.das@osumc.edu
-
Investigador principal:
- Kristine Orion, MD
-
Columbus, Ohio, Estados Unidos, 43214
- Recrutamento
- Ohio Health Riverside
-
Investigador principal:
- Joseph Campbell, MD
-
Contato:
- Regan Moran
- E-mail: Regan.Moran@ohiohealth.com
-
-
Oklahoma
-
Tulsa, Oklahoma, Estados Unidos, 74104
- Recrutamento
- Oklahoma Heart Institute
-
Investigador principal:
- Julia Chen, MD
-
Contato:
- Tia Whitaker
- E-mail: Tia.Whitaker@hillcrest.com
-
-
Oregon
-
Portland, Oregon, Estados Unidos, 97239
- Recrutamento
- Portland VA Medical Center
-
Investigador principal:
- Matthew Koopmann, MD
-
Contato:
- Rachel Nelson
- E-mail: Rachel.Nelson1@va.gov
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, Estados Unidos, 18015
- Recrutamento
- St. Luke's University Health Network
-
Investigador principal:
- Sharvil Sheth, MD
-
Contato:
- Jena Hagerty
- Número de telefone: 484-658-4982
- E-mail: Jena.Hagerty@sluhn.org
-
Philadelphia, Pennsylvania, Estados Unidos, 19104
- Recrutamento
- Hospital of the University of Pennsylvania
-
Contato:
- Carolina Reyes
- Número de telefone: 215-615-8036
- E-mail: carolina.reyes1@pennmedicine.upenn.edu
-
Investigador principal:
- Grace Wang, MD
-
Philadelphia, Pennsylvania, Estados Unidos, 19107
- Recrutamento
- Jefferson Clinical Research Institute
-
Contato:
- Jona Shperdheja
- E-mail: Jona.Shperdheja@jefferson.edu
-
Investigador principal:
- Michael Nooromid, MD
-
Pittsburgh, Pennsylvania, Estados Unidos, 15219
- Recrutamento
- University of Pittsburgh Medical Center
-
Contato:
- Judith Brimmeier
- E-mail: brimmeierja@upmc.edu
-
Investigador principal:
- Raymond Eid, MD
-
-
South Carolina
-
Greenville, South Carolina, Estados Unidos, 29605
- Recrutamento
- Prisma Health
-
Investigador principal:
- Mark P Androes, MD
-
Contato:
- Nikita Kasinger
- E-mail: Nikita.Kasinger@PrismaHealth.org
-
Contato:
- Maggie Salle
- E-mail: Margaret.Salle@PrismaHealth.org
-
-
South Dakota
-
Sioux Falls, South Dakota, Estados Unidos, 57108
- Recrutamento
- North Central Heart - A Division of Avera Heart Hospital
-
Investigador principal:
- Michael Bacharach, MD
-
Contato:
- Patty Eisenbraun, RN
- Número de telefone: 605-977-5336
- E-mail: peisenbraun@ncheart.com
-
-
Tennessee
-
Nashville, Tennessee, Estados Unidos, 37232
- Recrutamento
- Vanderbilt University Medical Center
-
Investigador principal:
- John Curci, MD
-
Contato:
- Celia Nunez
- E-mail: celia.m.nunez@vumc.org
-
Contato:
- Jennifer Scott
- E-mail: jennifer.scott@vumc.org
-
Nashville, Tennessee, Estados Unidos, 37212
- Ainda não está recrutando
- VA Tennessee Valley Healthcare System
-
Investigador principal:
- John Curci, MD
-
Contato:
- Sohpia Miner
- E-mail: Sophia.Miner@va.gov
-
-
Texas
-
Houston, Texas, Estados Unidos, 77004
- Recrutamento
- Houston Healthcare
-
Investigador principal:
- Kristofer Charlton-Ouw, MD
-
Contato:
- Swathi Potla
- E-mail: swathi.potla@hcahealthcare.com
-
Plano, Texas, Estados Unidos, 75093
- Recrutamento
- Baylor Scott & White Medical Center
-
Investigador principal:
- William Shutze, MD
-
Contato:
- Saba Arianpour
- E-mail: Saba.Arianpour@BSWHealth.org
-
-
Utah
-
Salt Lake City, Utah, Estados Unidos, 84132
- Recrutamento
- University of Utah Hospital
-
Contato:
- Julie Hales
- E-mail: Julie.Hales@hsc.utah.edu
-
Investigador principal:
- Cali Johnson, MD
-
-
Virginia
-
Fairfax, Virginia, Estados Unidos, 22031
- Recrutamento
- Inova Fairfax Medical Campus Inova Health Systems
-
Contato:
- Bhruga Shah
- E-mail: Bhruga.shah@inova.org
-
Investigador principal:
- Kendal Endicott, MD
-
Norfolk, Virginia, Estados Unidos, 23507
- Recrutamento
- Sentara Health
-
Investigador principal:
- David Dexter, MD
-
Contato:
- Angela Zahn
- E-mail: AXZAHN@sentara.com
-
-
Washington
-
Seattle, Washington, Estados Unidos, 98104
- Recrutamento
- University of Washington at Harborview Medical Center
-
Contato:
- Allison Larimore
- E-mail: alari@uw.edu
-
Investigador principal:
- Benjamin Starnes, MD
-
-
Wisconsin
-
Green Bay, Wisconsin, Estados Unidos, 54301
- Recrutamento
- Bellin Memorial Hospital
-
Investigador principal:
- Jason Ricci, MD
-
Contato:
- Katie Guilliams
- E-mail: Katherine.Guilliams@emplifyhealth.org
-
-
-
-
-
Auckland, Nova Zelândia, 1023
- Recrutamento
- Auckland City Hospital
-
Contato:
- Cynthia Corne
- Número de telefone: 21505 +64 9 307 4949
- E-mail: CorneC@adhb.govt.nz
-
Investigador principal:
- Andrew Holden, A/Prof
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Males and females ≥21 to ≤85 years of age. Females must be of non-childbearing potential (menopause or sterilization).
- Subject understands the purpose of the trial, agrees to voluntarily participate in the trial, signs the informed consent and is willing to complete the follow-up according to the requirements of the protocol.
- Infrarenal atherosclerotic fusiform abdominal aortic aneurysm from 3.5 cm to 5.0 cm (male) and 3.5 cm to 4.5 cm (female).
- Infrarenal aortic neck ≥ 15 mm in length and ≤ 29 mm in diameter.
- Overall AAA treatment length (distal renal to distal inferior margin of the aneurysm) not to exceed 130 mm.
- Iliac and femoral artery access, vessel size and morphology allow endovascular access of 14F (or larger) introducer sheaths and catheters.
- Subject meets American Society of Anesthesiology (ASA) grade 1 through 3 criteria, inclusive.
- Subject has > three-year life expectancy.
- Subject is able and willing to comply with all required follow-up clinic visits including CT scans (pre-randomization, 6, 12, 18, 24 months and annually up to 5 years) and blood draws.
Exclusion Criteria:
- Subject has an acutely ruptured, leaking, dissecting or emergent aneurysm.
- Subject has a symptomatic infrarenal abdominal aortic aneurysm.
- Subject has a mycotic or infected aneurysm.
- Subject has current vascular injury due to trauma.
- Subject's aneurysm is thoracic, suprarenal or juxtarenal.
- Previous surgical or endovascular aneurysm repair for abdominal aortic aneurysm.
- Subject has anatomy of diffuse, ulcerated, or extensive (shaggy) thrombus in the neck of the AAA, that in the opinion of the vascular surgeon/investigator, could result in embolization of the thrombus.
- Subject has anatomy of calcification, and/or plaque within the ilio-femoral arteries or severe infrarenal neck angulation that may compromise or does not allow delivery of the Introducer Sheath or the delivery catheter of the Nectero EAST System.
- Subject has had a myocardial infarction within six (6) months prior to enrollment or elevated CK enzymes or troponin indicative of an evolving MI prior to procedure.
- Subject has current angina, unstable angina, or other active cardiac condition such as congestive heart failure III and IV, atrial arrhythmia, ventricular arrhythmia, or valvular disease, requiring intervention.
- Subject has undergone other major surgery within the 30 days prior to enrollment.
- Subjects with any transient ischemic attack (TIA) or ischemic stroke within 3 months.
- Known allergy to contrast material that cannot be adequately premedicated, delivery system materials (i.e., nylon, polyurethane) and/or pentagalloylglucose (PGG).
- Subject is morbidly obese or has other clinical conditions that severely inhibit X-ray visualization of the aorta.
- Subject has connective tissue/collagen disorder (e.g., Marfan syndrome, vascular Ehlers-Danlos Syndrome, Loeys-Dietz Syndrome, Eaton Syndrome, Bessel-Hagen disease, etc.).
- Known contraindication to undergoing angiography or receiving systemic anticoagulation during the procedure.
- Subject has active systemic infection.
- Subject is participating in another research trial that could interfere with the results of the trial (e.g., drug trial).
- Subject has other medical, social, or psychological problems that, in the opinion of the investigator, preclude them from participation in the trial and to undergo the procedures and evaluations pre- and post-treatment.
- Subject has dialysis dependent renal failure or baseline serum creatinine level >2.5mg/dL or eGFR < 45 mL/min/1.73m2.
- Subjects with aminotransferase (ALT and/or AST) which is ≥1.5x upper limit of normal (ULN) or TB that is our of normal range for the evaluating laboratory.
- Subjects that may not tolerate the lowering of their systolic blood pressure to approximately 100mmHg, should not be considered for this study or treated using the Nectero EAST System.
- Subjects that may not be able to tolerate transient occlusion of the aorta should not be considered for this study.
- Subjects with saccular AAA.
- Subjects with rapidly expanding AAA (previous diameter increases of ≥0.5 cm in 6-months or ≥1 cm in 1 year) as these should be evaluated for immediate repair.
- Subjects who are not suitable for the Nectero EAST System treatment, as determined by the investigator.
- Subjects with INR out of normal range for the evaluating laboratory for a subject not on anti-coagulant therapy; or INR >3 for a subject on anti-coagulant therapy.
- Subjects with active/acute or a history of unstable chronic liver disease or current liver disease including but not limited to liver transplant, known genetic disorders such as Gilbert syndrome or other liver diseases.
- Subjects with cirrhosis (e.g., known history or new clinical diagnosis by elastography with a fibrosis score of F3 or F4 and/or steatosis grade of S3).
- Subjects with uncontrolled alcohol use disorder or current alcohol use putting them at risk of liver disease: including consumption of above one standard drink per day for women and two standard drinks per day for men.
- Subjects with known right-sided heart failure or pathologically dilated inferior vena cava or hepatic veins indicative of congestive hepatopathy.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Treatment Arm
Participants assigned to the treatment arm will undergo an endovascular procedure using the Nectero EAST System to deliver the Stabilizer Infusion Solution directly inside the aneurysm. This is a one-time local delivery of the product. Following treatment, surveillance of their AAA will be conducted using CT scans at 6 months, 12 months, 18 months, 24 months, and annually for 5 years. Intervention: Drug: Stabilizer |
Treated subjects will undergo an endovascular procedure with the Nectero EAST system and receive the Stabilizer Infusion Solution (drug) within 30 days of the study eligibility by CT scan as a one-time local delivery of the drug. |
|
Sem intervenção: Control Arm
Participants assigned to the control arm will undergo surveillance of their AAA using CT scans at 6 months, 12 months, 18 months, 24 months, and annually for 5 years. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Primary Endpoint
Prazo: 24 months
|
The primary endpoint is the composite of all AAA-related death, rupture and repair (open-surgical, EVAR, or clinically indicated for repair as adjudicated by a committee of clinical experts blinded to the assigned arm). |
24 months
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Growth
Prazo: 24 months
|
The growth over time in aneurysm diameter based on CT core laboratory readings. |
24 months
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Daniel Clair, MD, Vanderbilt University Medical Center
- Investigador principal: Grace Wang, MD, University of Pennsylvania
Publicações e links úteis
Links úteis
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- EAST002
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .